BROGI, SIMONE Statistiche

BROGI, SIMONE  

DIPARTIMENTO DI FARMACIA  

Mostra records
Risultati 1 - 20 di 128 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation 1-gen-2018 Brogi, S.; Brindisi, M.; Butini, S.; Kshirsagar, G. U.; Maramai, S.; Chemi, G.; Gemma, S.; Campiani, G.; Novellino, E.; Fiorenzani, P.; Pinassi, J.; Aloisi, A. M.; Gynther, M.; Venskutonyte, R.; Han, L.; Frydenvang, K.; Kastrup, J. S.; Pickering, D. S.
0365: Non-peptidic prokineticin receptor 1 agonist as a novel cardioprotective therapeutic 1-gen-2014 Gasser, Adeline; Nishi, Toshihide; Nguyen, Thu Lan; Urayama, Kyoji; Kurose, Hitoshi; Charavin, Marine; Brogi, Simone; Tafi, Andrea; Desaubry, Laurent; Nebigil, Canan
3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors 1-gen-2013 Brogi, S.; Papazafiri, P.; Roussis, V.; Tafi, A.
A Jocic-type approach for a practical and scalable synthesis of pyrrolonaphthoxazepine (PNOX)-based potent proapoptotic agents 1-gen-2018 Federico, S.; Khan, T.; Relitti, N.; Chemi, G.; Brindisi, M.; Brogi, S.; Novellino, E.; Zisterer, D. M.; Campiani, G.; Gemma, S.; Butini, S.
A light in the dark: State of the art and perspectives in optogenetics and optopharmacology for restoring vision 1-gen-2019 Chemi, G.; Brindisi, M.; Brogi, S.; Relitti, N.; Butini, S.; Gemma, S.; Campiani, G.
A repurposing approach for uncovering the anti-tubercular activity of FDA-approved drugs with Potential Multi-Targeting Profiles 1-gen-2019 Battah, B.; Chemi, G.; Butini, S.; Campiani, G.; Brogi, S.; Delogu, G.; Gemma, S.
A stereoselective approach to peptidomimetic BACE1 inhibitors 1-gen-2013 Butini, S.; Gabellieri, E.; Brindisi, M.; Giovani, S.; Maramai, S.; Kshirsagar, G.; Guarino, E.; Brogi, S.; La Pietra, V.; Giustiniano, M.; Marinelli, L.; Novellino, E.; Campiani, G.; Cappelli, A.; Gemma, S.
Abstract 411: Discovery and Cardioprotective Effects of the First Non-peptide Agonists of Prokineticin Receptor-1 1-gen-2015 Nebigil Canan, G; Gasser, Adeline; Brogi, Simone; Tafi, Andrea; Kurose, Hitoshi; Désaubry, Laurent
Activation of the Wnt Pathway by Small Peptides: Rational Design, Synthesis and Biological Evaluation 1-gen-2017 Brogi, S.; Maramai, S.; Brindisi, M.; Chemi, G.; Porcari, V.; Corallo, C.; Gennari, L.; Novellino, E.; Ramunno, A.; Butini, S.; Campiani, G.; Gemma, S.
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches to Treat Central Nervous System Disorders 1-gen-2019 Brogi, S.; Campiani, G.; Brindisi, M.; Butini, S.
Amyloid β fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin olive oil 1-gen-2020 Brogi, Simone; Sirous, Hajar; Calderone, Vincenzo; Chemi, Giulia
An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction 1-gen-2019 Sirous, Hajar; Chemi, Giulia; Campiani, Giuseppe; Brogi, Simone
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID-19 therapy 1-gen-2020 Citi, V.; Martelli, A.; Brancaleone, V.; Brogi, S.; Gojon, G.; Montanaro, R.; Morales, G.; Testai, L.; Calderone, V.
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues 1-gen-2018 Vallone, A.; D'Alessandro, S.; Brogi, S.; Brindisi, M.; Chemi, G.; Alfano, G.; Lamponi, S.; Lee, S. G.; Jez, J. M.; Koolen, K. J. M.; Dechering, K. J.; Saponara, S.; Fusi, F.; Gorelli, B.; Taramelli, D.; Parapini, S.; Caldelari, R.; Campiani, G.; Gemma, S.; Butini, S.
Artificial Intelligence in Translational Medicine 1-gen-2021 Brogi, Simone; Calderone, Vincenzo
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 1-gen-2022 Federico, S.; Khan, T.; Fontana, A.; Brogi, S.; Benedetti, R.; Sarno, F.; Carullo, G.; Pezzotta, A.; Saraswati, A. P.; Passaro, E.; Pozzetti, L.; Papa, A.; Relitti, N.; Gemma, S.; Butini, S.; Pistocchi, A.; Ramunno, A.; Vincenzi, F.; Varani, K.; Tatangelo, V.; Patrussi, L.; Baldari, C. T.; Saponara, S.; Gorelli, B.; Lamponi, S.; Valoti, M.; Saccoccia, F.; Giannaccari, M.; Ruberti, G.; Herp, D.; Jung, M.; Altucci, L.; Campiani, G.
Breakthroughs in Computational Approaches for Drug Discovery 1-gen-2017 Chemi, G; Brogi, S
Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II) 1-gen-2019 D'Alessandro, S.; Alfano, G.; Di Cerbo, L.; Brogi, S.; Chemi, G.; Relitti, N.; Brindisi, M.; Lamponi, S.; Novellino, E.; Campiani, G.; Gemma, S.; Basilico, N.; Taramelli, D.; Baratto, M. C.; Pogni, R.; Butini, S.
Butein as a potential binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: a computer-aided analysis 1-gen-2022 Kapoor, N.; Ghorai, S. M.; Khuswaha, P. K.; Bandichhor, R.; Brogi, S.
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 1-gen-2012 Castelli, M. P.; Casu, A.; Casti, P.; Lobina, C.; Carai, M. A. M.; Colombo, G.; Solinas, M.; Giunta, D.; Mugnaini, C.; Pasquini, S.; Tafi, A.; Brogi, S.; Gessa, G. L.; Corelli, F.